Emre Acaroglu1, Aysun Cetinyurek Yavuz2, Umit Ozgur Guler3, Selcen Yuksel4, Yasemin Yavuz5, Montse Domingo-Sabat6, Ferran Pellise6, Ahmet Alanay7, Francesco Sanchez Perez Grueso8, Frank Kleinstück9, Ibrahim Obeid10. 1. Ankara Spine Center, Iran Caddesi 45/2 Kavaklidere, Ankara, 06700, Turkey. acaroglue@gmail.com. 2. Clinistats EU, Zurich, Switzerland. 3. Ankara Spine Center, Iran Caddesi 45/2 Kavaklidere, Ankara, 06700, Turkey. 4. Yildirim Beyazit University, Ankara, Turkey. 5. Ankara University, Ankara, Turkey. 6. Hospital Universitari Vall d'Hebron, Barcelona, Spain. 7. Acibadem Maslak Hospital, Istanbul, Turkey. 8. Hospital Universitari La Paz, Madrid, Spain. 9. Schultess Clinic, Zurich, Switzerland. 10. Bordeaux University Hospital, Bordeaux, France.
Abstract
BACKGROUND: Adult spinal deformity (ASD) is a major public health problem. There are pros and cons of the available treatment alternatives (surgical or non-surgical) and it had been difficult to identify the best treatment modality. AIM: To construct a statistical DA model to identify the optimum overall treatment in ASD. METHODS: From an international multicentre database of ASD patients (968 pts), 535 who had completed 1 year follow-up (371 non-surgical-NS, 164 surgical-S), constitute the population of this study. DA was structured in two main steps of: (1) baseline analysis (assessing the probabilities of outcomes, assessing the values of preference-utilities-, combining information on probability and utility and assigning the quality adjusted life expectancy (QALE) for each treatment) and (2) sensitivity analysis. RESULTS: Four hundred and thirty-two patients (309 NS, 123 S) had baseline and 1 year follow-up ODI measurements. Overall, 104 (24.1 %) were found to be improved (a decrease in ODI > 8 points), 225 (52.1 %) unchanged (-8 > ODI > 8) and 65 deteriorated. Surgery presented with a higher chance of improvement (54.2 %) versus NS (9.7 %). The overall QALE ranged from 56 to 69 (of 100 years) and demonstrated better final QALE in the NS group (60 vs. 65, P = 0.0038), this group having started with higher QALE as well (56 vs. 65 years, P < 0.0001). There were improvements in overall QALE in both groups but this was significant only in the surgical group (S from 56 to 60 years, P < 0.0001; NS from 65 to 65 years, P = 0.27). In addition, in the subgroup of patients with significant baseline disability (ODI > 25) surgery appeared to yield marginally better final QALE (58 vs. 56 years, P = 0.1) despite very a similar baseline (54 vs. 54 years, P = 0.93). DISCUSSION AND CONCLUSIONS: This study demonstrated that a single best treatment modality for ASD may not exist. Conservative treatment appears to yield higher (up to 6 %) QALE compared to surgery, most probably secondary to a higher baseline QALE. On the other hand, surgery provides a significantly higher increase in QALE. Especially in patients with significant disability at baseline, the final QALE tended higher in the S group (although not significant). Finally, chances of a relevant improvement at first year turned out to be significantly lower with NS treatment.
BACKGROUND: Adult spinal deformity (ASD) is a major public health problem. There are pros and cons of the available treatment alternatives (surgical or non-surgical) and it had been difficult to identify the best treatment modality. AIM: To construct a statistical DA model to identify the optimum overall treatment in ASD. METHODS: From an international multicentre database of ASDpatients (968 pts), 535 who had completed 1 year follow-up (371 non-surgical-NS, 164 surgical-S), constitute the population of this study. DA was structured in two main steps of: (1) baseline analysis (assessing the probabilities of outcomes, assessing the values of preference-utilities-, combining information on probability and utility and assigning the quality adjusted life expectancy (QALE) for each treatment) and (2) sensitivity analysis. RESULTS: Four hundred and thirty-two patients (309 NS, 123 S) had baseline and 1 year follow-up ODI measurements. Overall, 104 (24.1 %) were found to be improved (a decrease in ODI > 8 points), 225 (52.1 %) unchanged (-8 > ODI > 8) and 65 deteriorated. Surgery presented with a higher chance of improvement (54.2 %) versus NS (9.7 %). The overall QALE ranged from 56 to 69 (of 100 years) and demonstrated better final QALE in the NS group (60 vs. 65, P = 0.0038), this group having started with higher QALE as well (56 vs. 65 years, P < 0.0001). There were improvements in overall QALE in both groups but this was significant only in the surgical group (S from 56 to 60 years, P < 0.0001; NS from 65 to 65 years, P = 0.27). In addition, in the subgroup of patients with significant baseline disability (ODI > 25) surgery appeared to yield marginally better final QALE (58 vs. 56 years, P = 0.1) despite very a similar baseline (54 vs. 54 years, P = 0.93). DISCUSSION AND CONCLUSIONS: This study demonstrated that a single best treatment modality for ASD may not exist. Conservative treatment appears to yield higher (up to 6 %) QALE compared to surgery, most probably secondary to a higher baseline QALE. On the other hand, surgery provides a significantly higher increase in QALE. Especially in patients with significant disability at baseline, the final QALE tended higher in the S group (although not significant). Finally, chances of a relevant improvement at first year turned out to be significantly lower with NS treatment.
Authors: Emre Acaroglu; Umit O Guler; Z Deniz Olgun; Yalcin Yavuz; Ferran Pellise; Montse Domingo-Sabat; Sule Yakici; Ahmet Alanay; Francesco Sanchez Perez-Grueso; Yasemin Yavuz Journal: Spine Deform Date: 2015-06-11
Authors: Scott L Parker; Stephen K Mendenhall; David Shau; Owoicho Adogwa; Joseph S Cheng; William N Anderson; Clinton J Devin; Matthew J McGirt Journal: J Neurosurg Spine Date: 2011-09-30
Authors: Michael D Daubs; Lawrence G Lenke; Gene Cheh; Georgia Stobbs; Keith H Bridwell Journal: Spine (Phila Pa 1976) Date: 2007-09-15 Impact factor: 3.468
Authors: Keith H Bridwell; Steven Glassman; William Horton; Christopher Shaffrey; Frank Schwab; Lukas P Zebala; Lawrence G Lenke; Joan F Hilton; Michael Shainline; Christine Baldus; David Wootten Journal: Spine (Phila Pa 1976) Date: 2009-09-15 Impact factor: 3.468
Authors: Ferran Pellisé; Alba Vila-Casademunt; Montse Ferrer; Montse Domingo-Sàbat; Juan Bagó; Francisco J S Pérez-Grueso; Ahmet Alanay; A F Mannion; Emre Acaroglu Journal: Eur Spine J Date: 2014-09-14 Impact factor: 3.134
Authors: Michael P Kelly; Jon D Lurie; Elizabeth L Yanik; Christopher I Shaffrey; Christine R Baldus; Oheneba Boachie-Adjei; Jacob M Buchowski; Leah Y Carreon; Charles H Crawford; Charles Edwards; Thomas J Errico; Steven D Glassman; Munish C Gupta; Lawrence G Lenke; Stephen J Lewis; Han Jo Kim; Tyler Koski; Stefan Parent; Frank J Schwab; Justin S Smith; Lukas P Zebala; Keith H Bridwell Journal: J Bone Joint Surg Am Date: 2019-02-20 Impact factor: 5.284
Authors: Sigurd H Berven; Steven J Kamper; Niccole M Germscheid; Benny Dahl; Christopher I Shaffrey; Lawrence G Lenke; Stephen J Lewis; Kenneth M Cheung; Ahmet Alanay; Manabu Ito; David W Polly; Yong Qiu; Marinus de Kleuver Journal: Eur Spine J Date: 2017-08-05 Impact factor: 3.134
Authors: David Christopher Kieser; Michael Charles Wyatt; Louis Boissiere; Kazunori Hayashi; Derek Thomas Cawley; Caglar Yilgor; Daniel Larrieu; Takashi Fujishiro; Ahmet Alanay; Emre Acaroglu; Frank Kleinstueck; Ferran Pellisé; Francisco Javier Sánchez Perez-Grueso; Anouar Bourghli; Jean-Marc Vital; Olivier Gille; Ibrahim Obeid Journal: J Spine Surg Date: 2019-12
Authors: Cem Karabulut; Selim Ayhan; Selcen Yuksel; Vugar Nabiyev; Alba Vila-Casademunt; Ferran Pellise; Ahmet Alanay; Francisco Javier Sanchez Perez-Grueso; Frank Kleinstuck; Ibrahim Obeid; Emre Acaroglu Journal: Int J Spine Surg Date: 2019-08-31
Authors: Rafael De la Garza Ramos; C Rory Goodwin; Amit Jain; Daniel Martinez-Ramirez; Isaac O Karikari; Daniel M Sciubba Journal: J Spine Surg Date: 2017-12